Prevalence, risk factors, and management practices of primary dysmenorrhea among young females

Samar Karout, Lama Soubra, Deema Rahme, Lina Karout, Hani M J Khojah, Rania Itani, Samar Karout, Lama Soubra, Deema Rahme, Lina Karout, Hani M J Khojah, Rania Itani

Abstract

Background: Primary dysmenorrhea (PD) is one of the most common gynecological conditions among young females, which has a significant negative impact on health-related quality of life and productivity. Despite its high prevalence, the evidence is limited regarding the management-seeking practices and its perceived effectiveness among females with PD.

Methods: This is a cross-sectional study conducted among 550 female students in six universities across Lebanon. The prevalence of PD, associated risk factors, and management-seeking practices were assessed using a self-administered questionnaire.

Results: The prevalence of PD was 80.9%. Most of the females with PD described their menstrual pain as moderate (56%) to severe (34.6%), which significantly affected their daily activities and studying ability (P < 0.001). The major risk factors associated with PD included heavy menstrual flow (adjusted odds ratio [AOR] = 10.28), family history of PD (AOR = 2.52), history of weight loss attempt (AOR = 2.05), and medical specialization (AOR = 1.663). Only 36.9% of females with PD sought formal medical advice. Most dysmenorrheic females (76.4%) received medications for the management of PD, and remarkably none of them took hormonal contraceptives. Drugs commonly used for PD were mefenamic acid (26.2%), ibuprofen (25%), and paracetamol (11.5%), which were administered when the pain started (58.2%). All medications were significantly effective in reducing the pain score (P = 0.001), and most NSAIDs were more potent than paracetamol in managing PD (P = 0.001). However, no significant difference in adverse effects among medications was revealed. Moreover, no superiority of any individual NSAID for pain relief was established. Nevertheless, mefenamic acid was associated with the lowest risk of abdominal pain (OR: 0.03, P = 0.005) and the highest risk of flank pain (OR = 12, P = 0.02).

Conclusions: Suboptimal management of PD is practiced among university students in Lebanon. Therefore, health care providers should educate dysmenorrheic females to optimize the self-management support of PD. Furthermore, future research is required to investigate females' misconceptions about hormonal contraceptives in the management of PD, aiming to raise awareness and correct misconceptions.

Keywords: Lebanon; Management-seeking practices; Menstrual pain; Non-steroidal anti-inflammatory drugs; Prevalence; Primary dysmenorrhea; Risk factors.

Conflict of interest statement

The authors declare that they have no competing interests and no affiliation with any organization with financial interest in the subject matter discussed in the manuscript.

© 2021. The Author(s).

References

    1. Mendiratta V. Primary and secondary dysmenorrhea, premenstrual syndrome, and premenstrual dysphoric disorder. In: Lobo RA, Gershenson DM, Lentz GM, editors. Comprehensive gynecology. 7. Philadelphia: Elsevier, Inc.; 2017. pp. 815–828.
    1. Chen CX, Shieh C, Draucker CB, Carpenter JS. Reasons women do not seek health care for dysmenorrhea. J Clin Nurs. 2018;27(1–2):301–308.
    1. Ramos-Pichardo JD, Ortega-Galán ÁM, Iglesias-López MT, Abreu-Sánchez A, Fernández-Martínez E. Why do some Spanish nursing students with menstrual pain fail to consult healthcare professionals? Int J Environ Res Public Health. 2020;17(21):8173.
    1. Bernardi M, Lazzeri L, Perelli F, Reis FM, Petraglia F. Dysmenorrhea and related disorders. F1000Research. 2017;6:1645.
    1. Calis KA, Dang DK, Kalantaridou SN, Erogul M. Dysmenorrhea: practice essentials, background, pathophysiology. Medscape. 2019 [cited 2021 Mar 8]. Available from .
    1. Santina T, Wehbe N, Ziade F. Exploring dysmenorrhoea and menstrual experiences among Lebanese female adolescents. East Mediterr Health J. 2012;18(8):857–863.
    1. Kabbara R, Ziade F, Gannagé-Yared MH. Prevalence and etiology of menstrual disorders in Lebanese university students. Int J Gynecol Obstet. 2014;126(2):177–178.
    1. Karout N, Hawai SM, Altuwaijri S. Prevalence and pattern of menstrual disorders among Lebanese nursing students. East Mediterr Health J. 2012;18(4):346–352.
    1. Alldredge BK, Corelli RL, Guglelmo BJ, Jacobson PA, Kradjan WA, Williams BR. Koda-Kimble & Young’s. Applied therapeutic: the clinial use of drugs. 10. Philadelphia: Lippincott Williams & Wilkins; 2013. pp. 1337–1357.
    1. Kuphal GJ. Dysmenorrhea. In: Rakel D, editor. Integrative medicine. 4. Philadelphia: Elsevier Inc.; 2018. pp. 569–577.e2.
    1. Itani R, Soubra L, Karout S, Rahme D, Karout L, Khojah HMJ. Primary dysmenorrhea: pathophysiology, diagnosis and treatment updates. Korean J Fam Med. 2021. (In press).
    1. Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a critical review. Eur Soc Hum Reprod Embryol. 2015;21(6):762–778.
    1. Chen L, Tang L, Guo S, Kaminga AC, Xu H. Primary dysmenorrhea and self-care strategies among Chinese college girls: a cross-sectional study. BMJ Open. 2019;9(9):1–9.
    1. Chan SSC, Yiu KW, Yuen PM, Sahota DS, Chung TKH. Menstrual problems and health-seeking behaviour in Hong Kong Chinese girls. Hong Kong Med J. 2017;15:18–23.
    1. Proctor M, Farquhar C. Diagnosis and management of dysmenorrhoea. BMJ. 2006;332(7550):1134–1138.
    1. Firouzi M, Zahedifard T, Salari P, Mazlom SR. Comparing the pattern of primary dysmenorrhea before and after childbirth. J Midwifery Reprod Health. 2019;7(1):1521–1528.
    1. Borgelt LM, Gunning KM. Disorders related to the menstrual cycle. In: Zeind CS, Carvalho MG, editors. Applied therapeutics: the clinical use of drugs. 11. Philadelphia: Wolter Kluwer; 2018. pp. 1005–1027.
    1. Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev. 2015;7:1–168.
    1. American College of Obstetricians and Gynecologists ACOG Committee Opinion No. 760: dysmenorrhea and endometriosis in the adolescent. Obstet Gynecol. 2018;132(6):e249–e258.
    1. Burnett M, Lemyre M. No. 345-primary dysmenorrhea consensus guideline. J Obstet Gynaecol Canada. 2017;39(7):585–595.
    1. Wong CL, Farquhar C, Roberts H, Proctor M. Oral contraceptive pill for primary dysmenorrhoea. Cochrane Database Syst Rev. 2009;2009(4):CD002120.
    1. Lindh I, Ellström AA, Milsom I. The effect of combined oral contraceptives and age on dysmenorrhoea: an epidemiological study. Hum Reprod. 2012;27(3):676–682.
    1. Maguire K, Westhoff C. The state of hormonal contraception today: established and emerging noncontraceptive health benefits. Am J Obstet Gynecol. 2011;205(4 Suppl):S4–8.
    1. Osayande AS, Mehulic S. Diagnosis and initial management of dysmenorrhea. Am Fam Phys. 2014;89(5):341–346.
    1. Armour M, Parry K, Al-Dabbas MA, Curry C, Holmes K, MacMillan F, et al. Self-care strategies and sources of knowledge on menstruation in 12,526 young women with dysmenorrhea: a systematic review and meta-analysis. PLoS ONE. 2019;14(7):e0220103.
    1. Matthewman G, Lee A, Kaur JG, Daley AJ. Physical activity for primary dysmenorrhea: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol. 2018;219(3):255.e1–255.e20.
    1. Jo J, Lee SH. Heat therapy for primary dysmenorrhea: a systematic review and meta-analysis of its effects on pain relief and quality of life. Sci Rep. 2018;8(1):16252.
    1. Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol. 2006;108(2):428–441.
    1. Daley AJ. Exercise and primary dysmenorrhoea: a comprehensive and critical review of the literature. Sports Med. 2008;38(8):659–670.
    1. Gagua T, Tkeshelashvili B, Gagua D. Primary dysmenorrhea: prevalence in adolescent population of Tbilisi, Georgia and risk factors. J Turk Ger Gynecol Assoc. 2012;13(3):162–168.
    1. Kural M, Noor NN, Pandit D, Joshi T, Patil A. Menstrual characteristics and prevalence of dysmenorrhea in college going girls. J Fam Med Prim care. 2015;4(3):426–431.
    1. Cozzolino M, Coccia ME, Lazzeri G, Basile F, Troiano G. Variables associated with endometriosis-related pain: a pilot study using a visual analogue scale. Fed Bras das Soc Ginecol e Obs. 2019;41(3):170–175.
    1. Acheampong K, Baffour-Awuah D, Ganu D, Appiah S, Pan X, Kaminga A, et al. Prevalence and predictors of dysmenorrhea, its effect, and coping mechanisms among adolescents in Shai Osudoku District, Ghana. Obstet Gynecol Int. 2019;1:1–8.
    1. Al-Matouq S, Al-Mutairi H, Al-Mutairi O, Abdulaziz F, Al-Basri D, Al-Enzi M, et al. Dysmenorrhea among high-school students and its associated factors in Kuwait. BMC Pediatr. 2019;19(1):80.
    1. Fernández-Martínez E, Onieva-Zafra MD, Parra-Fernández ML. The impact of dysmenorrhea on quality of life among Spanish female university students. Int J Environ Res Public Health. 2019;16(5):713.
    1. Larroy C. Comparing visual-analog and numeric scales for assessing menstrual pain. Behav Med. 2002;27(4):179–181.
    1. Ozder A, Salduz Z. The prevalence of dysmenorrhea and its effects on female university students’ quality of life: what can we do in primary care? Int J Clin Exp Med. 2020;13(9):6496–6505.
    1. Shah S, Makwana K, Shah P. Menstrual characteristics and prevalence of dysmenorrhea among female physiotherapy students. Int J Med Health Res. 2015;1(1):1–8.
    1. Daniel WW, Cross CL. Biostatistics: a foundation for analysis in the health sciences. 10. New York: Wiley; 2013.
    1. Parra-Fernández ML, Onieva-Zafra MD, Abreu-Sánchez A, Ramos-Pichardo JD, Iglesias-López MT, Fernández-Martínez E. Management of primary dysmenorrhea among university students in the South of Spain and family influence. Int J Environ Res Public Health. 2020;17(15):5570.
    1. Vilšinskaitė DS, Vaidokaitė G, Mačys Ž, Bumbulienė Ž. The risk factors of dysmenorrhea in young women. Wiad Lek. 2019;72(6):1170–1174.
    1. Subasinghe AK, Calancie O, Ewing L, Narducci LD, Horgan S, Khalid-Khan S. Prevalence and severity of dysmenorrhoea, and management options reported by young Australian women. Aust Fam Phys. 2016;45(11):829–834.
    1. Abu Helwa HA, Mitaeb AA, Al-Hamshri S, Sweileh WM. Prevalence of dysmenorrhea and predictors of its pain intensity among Palestinian female university students. BMC Womens Health. 2018;18(1):18.
    1. Ameade EPK, Amalba A, Mohammed BS. Prevalence of dysmenorrhea among University students in Northern Ghana; its impact and management strategies. BMC Womens Health. 2018;18(1):39.
    1. Grandi G, Ferrari S, Xholli A, Cannoletta M, Palma F, Volpe C, et al. Prevalence of menstrual pain in young women: what is dysmenorrhea? J Pain Res. 2012;5:169.
    1. Abreu-Sánchez A, Parra-Fernández ML, Onieva-Zafra MD, Ramos-Pichardo JD, Fernández-Martínez E. Type of dysmenorrhea, menstrual characteristics and symptoms in nursing students in Southern Spain. Healthcare (Basel, Switzerland) 2020;8(3):302.
    1. Burnett MA, Antao V, Black A, Feldman K, Grenville A, Lea R, et al. Prevalence of primary dysmenorrhea in Canada. J Obstet Gynaecol Canada. 2005;27(8):765–770.
    1. Alsaleem M. Dysmenorrhea, associated symptoms, and management among students at King Khalid University, Saudi Arabia: an exploratory study. J Fam Med Prim Care. 2018;7(4):769.
    1. Hu Z, Tang L, Chen L, Kaminga AC, Xu H. Prevalence and risk factors associated with primary dysmenorrhea among Chinese female university students: a cross-sectional study. J Pediatr Adolesc Gynecol. 2020;33(1):15–22.
    1. Al-Jefout M, Seham AF, Jameel H, Randa AQ, Ola AM, Oday AM, et al. Dysmenorrhea: prevalence and impact on quality of life among young adult Jordanian females. J Pediatr Adolesc Gynecol. 2015;28(3):173–185.
    1. Yesuf TA, Eshete NA, Sisay EA. Dysmenorrhea among university health science students, Northern Ethiopia: impact and associated factors. Int J Reprod Med. 2018;2018:1–5.
    1. Hapangama DK, Bulmer JN. Pathophysiology of heavy menstrual bleeding. Women’s Health. 2016;12(1):3–13.
    1. Ju H, Jones M, Mishra G. The prevalence and risk factors of dysmenorrhea. Epidemiol Rev. 2014;36(1):104–113.
    1. Latthe P, Mignini L, Gray R, Hills R, Khan K. Factors predisposing women to chronic pelvic pain: systematic review. Br Med J. 2006;332(7544):749–751.
    1. Qin LL, Hu Z, Kaminga AC, Luo BA, Xu HL, Feng XL, et al. Association between cigarette smoking and the risk of dysmenorrhea: a meta-analysis of observational studies. PLoS ONE. 2020;15(4):1–13.
    1. Ju H, Jones M, Mishra GD. Smoking and trajectories of dysmenorrhoea among young Australian women. Tob Control. 2016;25(2):195–202.
    1. Parveen N, Majeed R, Rajar UDM. Familial predisposition of dysmenorrhea among the medical students. Pak J Med Sci. 2009;25(5):857–860.
    1. Dehnavi Z, Jafarnejad F, Kamali Z. The Effect of aerobic exercise on primary dysmenorrhea: a clinical trial study. J Educ Health Promot. 2018;10(7):3.
    1. Chantler I, Mitchell D, Fuller A. Diclofenac potassium attenuates dysmenorrhea and restores exercise performance in women with primary dysmenorrhea. J Pain. 2009;10(2):191–200.
    1. Chia CF, Lai JHY, Cheung PK, Kwong LT, Lau FPM, Leung KH, et al. Dysmenorrhoea among Hong Kong university students: prevalence, impact, and management. Hong Kong Med J. 2013;19(3):222–228.
    1. National Institute for Health and Care Excellence. Heavy menstrual bleeding: assessment and management | Guidance. Nice Guidel. 2021.
    1. Habibzadeh F. Contraception in the Middle East. Lancet. 2012;380:1.
    1. Abdel-Salam DM, Albahlol IA, Almusayyab RB, Alruwaili NF, Aljared MY, Alruwaili MS, et al. Prevalence, correlates, and barriers of contraceptive use among women attending primary health centers in aljouf region, Saudi Arabia. Int J Environ Res Public Health. 2020;17(10):3552.
    1. Feng X, Wang X. Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs for patients with primary dysmenorrhea: a network meta-analysis. Mol Pain. 2018;14:1–14.
    1. Linda French MD. Dysmenorrhea. Am Fam Phys. 2005;71(2):285–291.
    1. Duggan KC, Walters MJ, Musee J, Harp JM, Kiefer JR, Oates JA, et al. Molecular basis for cyclooxygenase inhibition by the non-steroidal anti-inflammatory drug naproxen. J Biol Chem. 2010;285(45):34950–34959.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren